|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/28 |
| (11) | Patento numeris | 2996772 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14798473.6 |
| Europos patento paraiškos padavimo data | 2014-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/037761 |
| Data | 2014-05-13 |
| (87) | Numeris | WO 2014/186310 |
| Data | 2014-11-20 |
| (30) | Numeris | Data | Šalis |
| 201361822795 P | 2013-05-13 | US |
| (72) |
PROD`HOMME, Thomas, E., US
LING, Leona, E., US
BOSQUES, Carlos, J., US
MANNING, Anthony, US
KAUNDINYA, Ganesh, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, MA 02142,
US
|
| (54) | METHODS FOR THE TREATMENT OF NEURODEGENERATION |
| METHODS FOR THE TREATMENT OF NEURODEGENERATION |